Latest chemotherapy Stories
-- Animal model highly representative of late-stage ovarian cancer in women PHILADEPHIA, April 20, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen Ltd, (ASX:NRT;
-- TRXE-009 distinguished by ability to kill chemo-resistant adult and paediatric brain cancer cells SYDNEY, April 17, 2015 /PRNewswire/ -- US-Australian drug discovery company, Novogen, today
Don't let nausea stop you from doing what you want.
QUÉBEC CITY, April 16, 2015 /PRNewswire/ - Aeterna Zentaris Inc.
After almost five months of chemotherapy and radiation, the news was not good for Ken Cooper.
LUGANO, Switzerland and WOODCLIFF LAKE, N.J., April 15, 2015 /PRNewswire/ -- Helsinn Group and Eisai Inc.
NEW YORK, April 10, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Scientists have discovered a small RNA molecule known as miR-182 that can curb cancer-causing genes in mice with a deadly and incurable kind of brain tumor, glioblastoma mulitforme (GBM), according to a new study published in the journal Genes & Development.
Important Step Towards Increasing Treatment Options for Patients With This Serious Disease THOUSAND OAKS, Calif., April 6, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the
Hospital in the Netherlands To Begin Enrolling Patients NEW YORK, April 2, 2015 /PRNewswire/ -- Delcath Systems, Inc.
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
- an ornament or knob in the shape of a flower